Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) (2016 - 2024)

Historic EPS (Weighted Average and Diluted) for Harvard Bioscience (HBIO) over the last 16 years, with Q1 2024 value amounting to -$0.11.

  • Harvard Bioscience's EPS (Weighted Average and Diluted) fell 120000.0% to -$0.11 in Q1 2024 from the same period last year, while for Mar 2024 it was -$0.06, marking a year-over-year increase of 4545.45%. This contributed to the annual value of -$0.12 for FY2019, which is 41767.43% down from last year.
  • According to the latest figures from Q1 2024, Harvard Bioscience's EPS (Weighted Average and Diluted) is -$0.11, which was down 120000.0% from -$0.02 recorded in Q2 2023.
  • Over the past 5 years, Harvard Bioscience's EPS (Weighted Average and Diluted) peaked at $0.06 during Q2 2022, and registered a low of -$0.17 during Q1 2022.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.03 (2023), whereas its average is -$0.05.
  • Per our database at Business Quant, Harvard Bioscience's EPS (Weighted Average and Diluted) skyrocketed by 70000.0% in 2022 and then tumbled by 120000.0% in 2024.
  • Over the past 5 years, Harvard Bioscience's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.04 in 2020, then soared by 75.0% to -$0.01 in 2021, then surged by 700.0% to $0.06 in 2022, then tumbled by 133.33% to -$0.02 in 2023, then plummeted by 450.0% to -$0.11 in 2024.
  • Its EPS (Weighted Average and Diluted) was -$0.11 in Q1 2024, compared to -$0.02 in Q2 2023 and $0.01 in Q1 2023.